Medische hulpmiddelen en geneesmiddelen: Verschuivende grenzen in Brussel?

Size: px
Start display at page:

Download "Medische hulpmiddelen en geneesmiddelen: Verschuivende grenzen in Brussel?"

Transcription

1 Medische hulpmiddelen en geneesmiddelen: Verschuivende grenzen in Brussel? Sabina Hoekstra-van den Bosch Philips HealthTech, Global Regulations & Standards Arnhem, June 19, 2015

2 Samenvatting Verschil tussen geneesmiddel en medisch hulpmiddel (herhaling) Nieuw mechanisme voor statusbepaling van medische hulpmiddelen op Europees niveau Substance based medical devices 2 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

3 Fundamental difference between medical device and pharmaceutical 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

4 Simplified EU definition of a medical device Any product Intended for a medical purpose For humans Which does not act by pharmacological, immunological or metabolic means Fundamental difference with pharmaceutical products is mechanism of action 5 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

5 Statusbepaling van medische hulpmiddelen op Europees niveau 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

6 Statusbepaling medische hulpmiddelen in EU Huidige situatie Majority of cases: no doubt! In case of doubt: No seamless coherence between the definitions of medicinal products and medical device Decisive power lies with national judges Possibility to appeal to EU Court of Justice Demarcation procedure between pharmaceuticals and medical devices can be quite complicated! 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

7 Nieuw mechanisme voor statusbepaling? EU COM proposal MDR + Council changes 3 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

8 Wat betekent dit??? Sleutelwoorden/begrippen Art 2.2 of Directive 2001/83 Implementing acts MDCG 5 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

9 Medicinal Product Directive 2001/83, art 2.2 In cases of doubt, where, taking into account all its characteristics, a product may fall within the definition of a medicinal product and within the definition of a product covered by other Community legislation the provisions of this Directive shall apply. 4 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

10 Comitology Legislative process light System gradually developed from the 60-ties For implementing measures only Drafted by EU COM Voted upon by Council (Member States) by QMV European Parliament asked for the equal rights as co-legislator 2006: Veto right for European Parliament 10 1

11 Treaty of Lisbon (2010) Fundamental changes to comitology procedures, now called implementing acts Creation of a new legal instrument for delegation to EU Commission: delegated acts. Equality between EP and Council in limited control over both delegated and implementing acts (veto-right) And the winner is

12 Medical Device Coordination Group (MDCG) Commission proposal MDR art 80 Consisting of representatives of Member States (1 for MDs, 1 for IVDs, with an alternate for each) Members chosen for their competence and experience Members must be impartial Chaired and supported (logistically, technically and scientifically) by EU Commission Experts of other stakeholders (medical device industry, healthcare professionals, laboratories, patients and consumers) may be invited in subgroups as observer on case-by-case basis 12 1

13 Wat betekent dit als Medical Device Regulation van kracht is? Regulation (=Verordening) rechtstreeks van toepassing in alle lidstaten Statusbepaling dmv Implementing acts met Europese Commissie aan het roer MDCG (lidstaten) worden tevoren geraadpleegd Beroep tegen Implementing act ingewikkeld (voor gevorderde Europees juristen.) 5 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

14 substance based medical devices 13 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

15 substance based medical devices Background Increasing number of ingested or absorbed products with medical claims Not possible to demonstrate that (some of) these products have any pharmacological, immunological or metabolic action/effect Historically a lot of these products have been placed on the market as medicinal products Identical products regulated as medicinal products, medical devices or food supplements. Differences in interpretation between Member States, but also within Member States. When the Medical Device Directive was drafted (mid-eighties), legislators did not intend to cover products which are ingested or absorbed, so some adaptation might be needed in order to cover these products properly. Examples: some nasal sprays, gels for vaginal discomfort, throat lozenges, toothpastes for sensitive teeth, flushing solutions, creams to treat or prevent minor skin irritations, comfort eye drops or anti-flatulence products 15 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

16 substance based medical devices Solution: substance based medical devices defined in MDR: Adaptation of Classification rules General Safety and Performance Requirements Conformity Assessment Procedures Labelling and Instructions for use Referral to relevant provisions in 2001/83 Provoked lots of intense discussion, e.g. on Definition Risk classification 15 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

17 Definition of substance based medical devices EU COM proposal MDR + Council changes Devices that are composed of substances or combinations of substances that are intended to be ingested inhaled or administered rectally or vaginally introduced into the human body via a body orifice, or applied on skin and that are absorbed by or locally dispersed in the human body 16 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

18 Classification of substance based medical devices (Annex VII) 19 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

19 General Safety and Performance Requirements MDR Annex I 14 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

20 Labelling MDR Annex I, Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

21 Instructions for use MDR Annex I, Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

22 Technical documentation Annex II Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

23 Dank voor uw aandacht! 24 Arnhem, June 19, 2015 Philips HealthTech, Global Regulations & Standards

24

Implementing & Delegated Acts

Implementing & Delegated Acts Implementing & Delegated Acts Some Principles jos.dumortier@timelex.eu 1 Executive Acts: why? filling in the gaps or dealing with details jos.dumortier@timelex.eu 2 Legislative Process Commission PROPOSES

More information

The information contained in these slides is for general purposes only and presents the state of knowledge at November 30, 2011

The information contained in these slides is for general purposes only and presents the state of knowledge at November 30, 2011 1 The information contained in these slides is for general purposes only and presents the state of knowledge at November 30, 2011 No rights can be derived from this information The Medicines Evaluation

More information

CE Marking Changing & Evolving Requirements September 2013 2013 BSI Healthcare Roadshow

CE Marking Changing & Evolving Requirements September 2013 2013 BSI Healthcare Roadshow CE Marking Changing & Evolving Requirements September 2013 2013 BSI Healthcare Roadshow Existing Directives 2 Directive 93/42/EEC 1. Check Scope of Medical Device Directive (Article 1) 2. Determine Device

More information

Update: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR)

Update: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR) Update: Proposed Medical Device Regulation (MDR) & IVD Regulation (IVDR) Paul Brooks Healthcare Solutions Disclaimer The new regulations are not finalized and subject to change http://medicaldevices.bsigroup.com/en-us/resources/whitepapers-and-articles/

More information

Draft conclusions of the Council and of the Member States on the civil and commercial justice systems of the Member States

Draft conclusions of the Council and of the Member States on the civil and commercial justice systems of the Member States COUNCIL OF THE EUROPEAN UNION Brussels, 20 February 2014 6771/14 FREMP 29 JAI 103 JUSTCIV 44 NOTE from: to: Subject: Coreper Council Draft conclusions of the Council and of the Member States on the civil

More information

Informatiebeveiliging volgens ISO/IEC 27001:2013

Informatiebeveiliging volgens ISO/IEC 27001:2013 Informatiebeveiliging volgens ISO/IEC 27001:2013 Dave Hagenaars, directeur BSI Group Nederland Copyright 2012 BSI. All rights reserved. Inhoud Wie zijn wij? Waarom informatiebeveiliging? Wat is de relevantie

More information

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP DISCLAIMER: The EU reserves the right to make subsequent modifications to this text and to complement its proposals at a later stage, by modifying, supplementing or withdrawing all, or any part, at any

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health products and systems Medicinal products quality, safety and efficacy Brussels, 15 May 2013 sanco.ddg1.d.6(2013)1154216 THE RULES GOVERNING

More information

Brief Summary on the Philippine B bilateral Air Services Agreement

Brief Summary on the Philippine B bilateral Air Services Agreement EUROPEAN COMMISSION Brussels, 27.5.2016 COM(2016) 303 final 2016/0156 (NLE) Proposal for a COUNCIL DECISION on the conclusion of the Agreement between the European Union and the Government of the Republic

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 4.1

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 4.1 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, SANCO/D/6/SF/mg/ddg1.d.6(2013) IMPORTATION OF ACTIVE SUBSTANCES

More information

Amsterdam Institute for Advanced labour Studies Coordination of national social security in the EU Jan Cremers Working Paper 10-89 March 2010

Amsterdam Institute for Advanced labour Studies Coordination of national social security in the EU Jan Cremers Working Paper 10-89 March 2010 AIAS Amsterdam Institute for Advanced labour Studies Coordination of national social security in the EU Jan Cremers Working Paper 10-89 March 2010 AIAS University of Amsterdam Acknowledgement This paper

More information

Possible Revision of the Commission Decision on the minimum set of leased lines. Deadline: 31 March 2004

Possible Revision of the Commission Decision on the minimum set of leased lines. Deadline: 31 March 2004 EUROPEAN COMMISSION Information Society Directorate-General Communication Services: Policy and Regulatory Framework Policy development and regulatory framework Brussels, 3 March 2004 PUBLIC CALL FOR INPUT

More information

A COMPARATIVE TABLE OF THE CURRENT EC AND EU TREATIES AS AMENDED BY THE TREATY OF LISBON

A COMPARATIVE TABLE OF THE CURRENT EC AND EU TREATIES AS AMENDED BY THE TREATY OF LISBON Foreign and Commonwealth Office London A COMPARATIVE TABLE OF THE CURRENT EC AND EU TREATIES AS AMENDED BY THE TREATY OF LISBON 9.25 A COMPARATIVE TABLE OF THE CURRENT EC AND EU TREATIES AS AMENDED BY

More information

No. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER 5 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008

No. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER 5 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008 COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9637/08 SAN 88 DENLEG 52 VETER 7 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 9392/08 SAN 77 DENLEG 48 VETER

More information

Response from REGLEG to the Consultation on the Common Strategic Framework

Response from REGLEG to the Consultation on the Common Strategic Framework 1 Response from REGLEG to the Consultation on the Common Strategic Framework REGLEG welcomes the early publication of the Commission Staff Working Document Elements for a Common Strategic Framework 2014

More information

Software within the medical device regulatory framework in the EU

Software within the medical device regulatory framework in the EU Software within the medical device regulatory framework in the EU E-HEALTH WEEK (AMSTERDAM, 10 JUNE 2016) Erik Hansson, Deputy Head of Unit, DG GROWTH - Health Technology and Cosmetics, European Commission

More information

A Comparative Case Study on the Relationship between EU Unity and its Effectiveness in Multilateral Negotiations

A Comparative Case Study on the Relationship between EU Unity and its Effectiveness in Multilateral Negotiations Is the Sum More than its Parts? A Comparative Case Study on the Relationship between EU Unity and its Effectiveness in Multilateral Negotiations PhD thesis by: Louise van Schaik, July 2010 Promoter/ PhD

More information

TELECOM SOCIETY 2 JULI 2015. Over de moeizame verhouding tussen de privacywet en big data. En wat we daaraan kunnen doen. prof mr.

TELECOM SOCIETY 2 JULI 2015. Over de moeizame verhouding tussen de privacywet en big data. En wat we daaraan kunnen doen. prof mr. TELECOM SOCIETY 2 JULI 2015 Over de moeizame verhouding tussen de privacywet en big data. En wat we daaraan kunnen doen prof mr. Gerrit-Jan Zwenne roadmap A. WTF is IoT? What is datafication? And what

More information

Official Journal of the European Union. (Acts whose publication is obligatory)

Official Journal of the European Union. (Acts whose publication is obligatory) 27.12.2006 L 378/1 I (Acts whose publication is obligatory) REGULATION (EC) No 1901/2006 OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 12 December 2006 on medicinal products for paediatric use and amending

More information

Lisbon Treaty: impact on EU decision-making

Lisbon Treaty: impact on EU decision-making Lisbon Treaty: impact on EU decision-making Daniela Weber-Rey 19 October 2011 Presentation to EIOPA Stakeholder Groups - joint meeting Overview Before and after the Lisbon Treaty Hierarchy of legislation

More information

Authorisation and Restriction Newsletter

Authorisation and Restriction Newsletter Authorisation and Restriction Newsletter August 2010, N 1 The information contained in this document is intended for guidance only and whilst the information is provided in utmost good faith and has been

More information

Medical Devices: CE Marking Step-by Step

Medical Devices: CE Marking Step-by Step Medical Devices: CE Marking Step-by Step Sylvia Mohr Standards Specialist U.S. Mission to the European Union 1 Introduction CE marking in 8 Steps Overview intended purpose - technical documentation classification

More information

Assuring the Cloud. Hans Bootsma Deloitte Risk Services hbootsma@deloitte.nl +31 (0)6 1098 0182

Assuring the Cloud. Hans Bootsma Deloitte Risk Services hbootsma@deloitte.nl +31 (0)6 1098 0182 Assuring the Cloud Hans Bootsma Deloitte Risk Services hbootsma@deloitte.nl +31 (0)6 1098 0182 Need for Assurance in Cloud Computing Demand Fast go to market Support innovation Lower costs Access everywhere

More information

8485/15 SC/GDLC/io 1 DGB 1

8485/15 SC/GDLC/io 1 DGB 1 Council of the European Union Brussels, 5 May 2015 (OR. en) 8485/15 NOTE From: To: Special Committee on Agriculture Council No. prev. doc.: 7524/2/15 REV 2 Subject: AGRI 242 AGRIORG 26 AGRILEG 100 AGRIFIN

More information

COMMISSION RECOMMENDATION. of XXX

COMMISSION RECOMMENDATION. of XXX EUROPEAN COMMISSION Brussels, XXX [ ](2013) XXX draft COMMISSION RECOMMENDATION of XXX on the use of common methods to measure and communicate the life cycle environmental performance of products and organisations

More information

EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical Devices

EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical Devices EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical 03/09/2013 In Vitro Diagnostic medical devices include all tests performed to provide a diagnosis by assessing

More information

CLP regulation & 2015 deadline for mixtures

CLP regulation & 2015 deadline for mixtures CLP regulation & 2015 deadline for mixtures CEFIC REACH Information and Experience Exchange Forum Zaventem, 18 December 2013 Maurits-Jan Prinz European Commission DG Enterprise & Industry Table of contents

More information

FRAMEWORK FOR CONSULTATION OF CEIOPS AND OTHER STAKEHOLDERS ON SOLVENCY II

FRAMEWORK FOR CONSULTATION OF CEIOPS AND OTHER STAKEHOLDERS ON SOLVENCY II Annex 1 to MARKT/2506/04-EN FRAMEWORK FOR CONSULTATION OF CEIOPS AND OTHER STAKEHOLDERS ON SOLVENCY II Purpose of this document The purpose of this paper is to consult the Insurance Committee on a framework

More information

Emerging Device Topics for Regulatory Consideration.. Janine Jamieson May 2015

Emerging Device Topics for Regulatory Consideration.. Janine Jamieson May 2015 Emerging Device Topics for Regulatory Consideration. Janine Jamieson May 2015 Disclaimer These are my personal views and not necessarily those of MHRA as an organisation. 2 European regulation of combination

More information

SAFETY DATA SHEET EVO-STIK PLUMBERS MAIT

SAFETY DATA SHEET EVO-STIK PLUMBERS MAIT Revision Date November 2012 Revision 9 1 / 5 SAFETY DATA SHEET According to Regulation (EC) No 1907/2006 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier

More information

COMMISSION OF THE EUROPEAN COMMUNITIES GREEN PAPER

COMMISSION OF THE EUROPEAN COMMUNITIES GREEN PAPER EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 11.11.2009 COM(2009) 624 final GREEN PAPER on obtaining evidence in criminal matters from one Member State to another and securing its admissibility

More information

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL EUROPEAN COMMISSION Brussels, 15.7.2015 COM(2015) 345 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Review of Directive 2010/30/EU of the European Parliament and of the Council

More information

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Proposal for an Interinstitutional Agreement on Better Regulation

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Proposal for an Interinstitutional Agreement on Better Regulation EUROPEAN COMMISSION Strasbourg, 19.5.2015 COM(2015) 216 final COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Proposal for an Interinstitutional Agreement on Better Regulation

More information

Handling impact assessments in Council

Handling impact assessments in Council QC-76-06-353-EN-C EN COUNCIL OF THE EUROPEAN UNION GENERAL SECRETARIAT Handling impact assessments in Council INDICATIVE GUIDANCE FOR WORKING PARTY CHAIRS ISBN 92-824-3284-X,!7IJ2I2-edcieg! kg611572cee_couv.indd

More information

REGULATION (EEC) No 2309/93

REGULATION (EEC) No 2309/93 REGULATION (EEC) No 2309/93 Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use

More information

TRACTATENBLAD VAN HET KONINKRIJK DER NEDERLANDEN. JAARGANG 2015 Nr. 93

TRACTATENBLAD VAN HET KONINKRIJK DER NEDERLANDEN. JAARGANG 2015 Nr. 93 16 (2015) Nr. 1 TRACTATENBLAD VAN HET KONINKRIJK DER NEDERLANDEN JAARGANG 2015 Nr. 93 A. TITEL Verdrag tussen het Koninkrijk der Nederlanden en het Internationaal Strafhof betreffende afspraken voor de

More information

EUROPEAN COMMISSION Employment, Social Affairs and Equal Opportunities DG COMMUNITY PROGRAMME FOR EMPLOYMENT AND SOCIAL SOLIDARITY (PROGRESS)

EUROPEAN COMMISSION Employment, Social Affairs and Equal Opportunities DG COMMUNITY PROGRAMME FOR EMPLOYMENT AND SOCIAL SOLIDARITY (PROGRESS) EUROPEAN COMMISSION Employment, Social Affairs and Equal Opportunities DG Directorate-General General Coordination, Interinstitutional Relations Brussels, 21 December 2006 01/FB D(2006) PROGRESS/003/2006

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health systems and products Medicinal products quality, safety and efficacy Brussels, IMPORTATION OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS

More information

2. Europol's cooperation agreements with third countries and international organisations (Art. 31);

2. Europol's cooperation agreements with third countries and international organisations (Art. 31); Council of the European Union General Secretariat Brussels, 29 September 2015 (OR. en) DS 1532/15 LIMITE MEETING DOCUMENT From: To: Presidency Delegations No. prev. doc.: DS 1497/15, DS 1371/15, DS 1289/1/15

More information

GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES

GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES Foreword GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES These guidance notes do not aim to be a definite interpretation of National Laws and/or regulations and are for guidance purpose only.

More information

REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT

REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT EUROPEAN COMMISSION Brussels, 4.2.2015 COM(2015) 43 final REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT 32nd Annual Report from the Commission to the Council and the European Parliament

More information

1. Product and Company Identification

1. Product and Company Identification Material Safety Data Sheet Oligonucleotide (unmodified and modified) English 1 / 7 1. Product and Company Identification 1.1 Product identifier Chemical Name / Trade Name: Synthetic Nucleic Acid (Oligonucleotide)

More information

HSE: Frequently Asked Questions

HSE: Frequently Asked Questions HSE: Frequently Asked Questions Q1 - What is GHS? A GHS refers to the United Nations (UN) Globally Harmonised System of Classification and Labelling of Chemicals. The UN published GHS in its publication

More information

Strong support. Remaining concerns

Strong support. Remaining concerns EORTC opinion on the proposal for an EU Regulation on clinical trials on medicinal products for human use and the 7 th of June ENVI report on this proposal It is clear that the Commission and appointed

More information

Council of the European Union Brussels, 22 December 2015 (OR. en)

Council of the European Union Brussels, 22 December 2015 (OR. en) Council of the European Union Brussels, 22 December 2015 (OR. en) 15548/15 POLG 185 NOTE From: To: General Secretariat of the Council Delegations Subject: Provisional agendas for Council meetings, during

More information

ISACA Roundtable. Cobit and Grab@Pizza 7 september 2015

ISACA Roundtable. Cobit and Grab@Pizza 7 september 2015 1 ISACA Roundtable 7 september 2015 ISACA Roundtable Cobit and Grab@Pizza 7 september 2015 2015 KPN Corporate Market B.V. ISACA, is a registered trademark of the Information Systems Audit and Control Association

More information

Acties van Phytofar in het kader van de reductieplannen

Acties van Phytofar in het kader van de reductieplannen Acties van Phytofar in het kader van de reductieplannen Marc Sneyders KVIV Studiedag 06 april 2011 Less use of crop protection products = More sustainability Pesticides This is what most people think about

More information

UEMS 2004 / 47 EN ADOPT ED

UEMS 2004 / 47 EN ADOPT ED EUROPEAN UNION OF MEDICAL SPECIALISTS Kroonlaan 20 Avenue de la Couronne tel: +32-2-649.51.64 B-1050 - BRUSSELS fax: +32-2-640.37.30 www.uems.net uems@skynet.be NEW STATUTES UEMS 2004 / 47 EN ADOPT ED

More information

Behavioral Targeting Legal Developments in Europe and the Netherlands

Behavioral Targeting Legal Developments in Europe and the Netherlands 1 Behavioral Targeting Legal Developments in Europe and the Netherlands Frederik Zuiderveen Borgesius Ph.D researcher, focusing on behavioral targeting and privacy law Institute for Information Law, University

More information

COMMISSION DECISION. of 19.5.2015. establishing the REFIT Platform

COMMISSION DECISION. of 19.5.2015. establishing the REFIT Platform EUROPEAN COMMISSION Strasbourg, 19.5.2015 C(2015) 3261 final COMMISSION DECISION of 19.5.2015 establishing the REFIT Platform EN EN COMMISSION DECISION of 19.5.2015 establishing the REFIT Platform THE

More information

Kansen in KP7 NMP. Aansluitend op de HTSM Roadmap Nanotechnologie. 11 juni 2012. Melvin A. Kasanrokijat

Kansen in KP7 NMP. Aansluitend op de HTSM Roadmap Nanotechnologie. 11 juni 2012. Melvin A. Kasanrokijat Kansen in KP7 NMP Aansluitend op de HTSM Roadmap Nanotechnologie 11 juni 2012 Melvin A. Kasanrokijat Mogelijkheden in KP7 - Cooperation Groot programma met 10 verschillende thema s NMP, ICT, Health, Energy,

More information

SAFETY DATA SHEET BOSTIK AQUAGRIP 536

SAFETY DATA SHEET BOSTIK AQUAGRIP 536 Revision Date November 2014 1 / 6 SAFETY DATA SHEET BOSTIK AQUAGRIP 536 According to Regulation (EC) No 1907/2006 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1.

More information

RECOMMENDATION 2013/473/EU ON NOTIFIED BODIES AUDITS

RECOMMENDATION 2013/473/EU ON NOTIFIED BODIES AUDITS RECOMMENDATION 2013/473/EU ON NOTIFIED BODIES AUDITS Questions and Problems in the Field 1 RAin Dr. Angela Graf Bundesverband der Arzneimittel-Hersteller 28. Oktober 2014 RECOMMENDATION 2013/473/EU IN

More information

002475/EU XXV. GP. Eingelangt am 18/11/13 COUNCIL OF THE EUROPEAN UNION. Brussels, 18 November 2013 (OR. en)

002475/EU XXV. GP. Eingelangt am 18/11/13 COUNCIL OF THE EUROPEAN UNION. Brussels, 18 November 2013 (OR. en) 002475/EU XXV. GP Eingelangt am 18/11/13 COUNCIL OF THE EUROPEAN UNION Brussels, 18 November 2013 (OR. en) 15552/13 Interinstitutional File: 2013/0354 (NLE) AELE 64 EEE 43 CHIMIE 116 AGRILEG 150 LEGISLATIVE

More information

HIPPO STUDY DG Education And Culture Study On The Cooperation Between HEIs And Public And Private Organisations In Europe. Valorisatie 9/26/2013

HIPPO STUDY DG Education And Culture Study On The Cooperation Between HEIs And Public And Private Organisations In Europe. Valorisatie 9/26/2013 Valorisatie Hoe goed doen we het in Nederland en doet het HBO het anders dan universiteiten? Peter van der Sijde Todd Davey HIPPO STUDY DG Education And Culture Study On The Cooperation Between HEIs And

More information

Authorisation and Restriction: Interplay and other Strategic Considerations

Authorisation and Restriction: Interplay and other Strategic Considerations Authorisation and Restriction: Interplay and other Strategic Considerations Informa Conference on REACH Montfort, Jean-Philippe Partner +32 (0)2 551 5970 jpmontfort@mayerbrown.com Brussels, 5 March 2012

More information

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP) Presented by: Patrick Costello Scientific Administrator, European Medicines Agency An agency of the European

More information

GUIDANCE DOCUMENT No. 10 ON THE APPLICATION OF THE DIRECTIVE ON THE SAFETY OF TOYS MUSIC INSTRUMENTS

GUIDANCE DOCUMENT No. 10 ON THE APPLICATION OF THE DIRECTIVE ON THE SAFETY OF TOYS MUSIC INSTRUMENTS EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL New Approach Industries, Tourism and CSR International regulatory agreements, toys safety, CSR Last updated: 21/12/2010 GUIDANCE DOCUMENT

More information

DISCUSSION NON-PAPER. How to put ideas for cooperation under TTIP into practice a few examples

DISCUSSION NON-PAPER. How to put ideas for cooperation under TTIP into practice a few examples 1 DISCUSSION NON-PAPER How to put ideas for cooperation under TTIP into practice a few examples Introductory Note: This paper provides descriptions of various processes under REACH and CLP, and is destined

More information

002400/EU XXV. GP. Eingelangt am 18/11/13. Brussels, 16 November 2013 COUNCIL OF THE EUROPEAN UNION 16030/1/13 REV 1

002400/EU XXV. GP. Eingelangt am 18/11/13. Brussels, 16 November 2013 COUNCIL OF THE EUROPEAN UNION 16030/1/13 REV 1 002400/EU XXV. GP Eingelangt am 18/11/13 COUNCIL OF THE EUROPEAN UNION Brussels, 16 November 2013 Interinstitutional File: 2013/0255 (APP) 16030/1/13 REV 1 EPPO 20 EUROJUST 114 CATS 77 FIN 735 COPEN 191

More information

PUBLIC COU CIL OF THE EUROPEA U IO. Brussels, 4 July 2011 12373/11. Interinstitutional File: 2011/0023 (COD) LIMITE

PUBLIC COU CIL OF THE EUROPEA U IO. Brussels, 4 July 2011 12373/11. Interinstitutional File: 2011/0023 (COD) LIMITE eil UE PUBLIC COU CIL OF THE EUROPEA U IO Brussels, 4 July 0 Interinstitutional File: 0/00 (COD) DOCUME T PARTIALLY ACCESSIBLE TO THE PUBLIC (4.0.0) 7/ LIMITE GE VAL 7 AVIATIO 8 DATAPROTECT 7 CODEC 7 OTE

More information

Offshore Wind in Germany

Offshore Wind in Germany Offshore Wind in Germany Lessons to be learned voor NL ir. Han van Asten, Programma manager TenneT Den Haag, KIVI NIRIA, 'Wind op Zee = Winst voor Nederland', 20 sep 2012 KIVI NIRIA Wind op Zee = Winst

More information

12040/1/15 REV 1 LES/ns 1 DG B 3B

12040/1/15 REV 1 LES/ns 1 DG B 3B Council of the European Union Brussels, 21 September 2015 (OR. en) Interinstitutional File: 2012/0266 (COD) 12040/1/15 REV 1 NOTE From: To: General Secretariat of the Council PHARM 36 SAN 281 MI 567 COMPET

More information

Changes to Medical Device Regulations

Changes to Medical Device Regulations Changes to Medical Device Regulations How these will affect distributors? IMSTA Breakfast Briefing, 24 October 2013 Niall MacAleenan Medical Device Lead, IMB. Slide 1 Content Revision of the medical device

More information

16525/1/12 REV 1 GS/np 1 DG D 2B

16525/1/12 REV 1 GS/np 1 DG D 2B COUNCIL OF THE EUROPEAN UNION Brussels, 3 December 2012 Interinstitutional File: 2012/0011 (COD) 16525/1/12 REV 1 DATAPROTECT 132 JAI 819 DAPIX 145 MI 753 FREMP 141 DRS 131 CODEC 2744 NOTE from: Presidency

More information

Regulatory Strategy for Drug-Device Combinations By John Worroll

Regulatory Strategy for Drug-Device Combinations By John Worroll THE MEDICAL DEVICE CONSULTING, AUDITING & TRAINING EXPERTS Regulatory Strategy for Drug-Device Combinations By John Worroll Introduction Drug-device combinations have always been a challenge to the regulatory

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex

More information

RULES OF THE TENNESSEE DEPARTMENT OF INTELLECTUAL AND DEVELOPMENTAL DISABILITIES

RULES OF THE TENNESSEE DEPARTMENT OF INTELLECTUAL AND DEVELOPMENTAL DISABILITIES RULES OF THE TENNESSEE DEPARTMENT OF INTELLECTUAL AND DEVELOPMENTAL DISABILITIES CHAPTER 0465-01-03 ADMINISTRATION OF MEDICATION BY UNLICENSED PERSONNEL TABLE OF CONTENTS 0465-01-03-.01 Purpose 0465-01-03-.06

More information

Section 1: Development of the EU s competence in the field of police and judicial cooperation in criminal matters

Section 1: Development of the EU s competence in the field of police and judicial cooperation in criminal matters CALL FOR EVIDENCE ON THE GOVERNMENT S REVIEW OF THE BALANCE OF COMPETENCES BETWEEN THE UNITED KINGDOM AND THE EUROPEAN UNION Police and Criminal Justice LEGAL ANNEX Section 1: Development of the EU s competence

More information

Evaluation reports from the Commission on Reimbursement of Medicines (CRM) and the Medical Pharmaceutical Committee (MFC) as specific target group

Evaluation reports from the Commission on Reimbursement of Medicines (CRM) and the Medical Pharmaceutical Committee (MFC) as specific target group Evaluation reports from the Commission on Reimbursement of Medicines (CRM) and the Medical Pharmaceutical Committee (MFC) as specific target group Philippe Van Wilder RIZIV-INAMI Belgian National Health

More information

COMMISSION REGULATION (EU) No. of XXX

COMMISSION REGULATION (EU) No. of XXX EUROPEAN COMMISSION Brussels, XXX [...1(2014) XXX draft COMMISSION REGULATION (EU) No of XXX amending Regulation (EC) No 850/2004 of the European Parliament and of the Council on persistent organic pollutants

More information

Pharmacy Technician Training Program. Minimum Competencies

Pharmacy Technician Training Program. Minimum Competencies 1. Pharmacy Practice Pharmacy Technician Training Program Minimum Competencies 1.1 The candidate shall be familiar with the mission of pharmacy and the various permitted pharmacy practice sites. The candidate

More information

EBA/RTS/2016/01. 13 January 2016. Final Report

EBA/RTS/2016/01. 13 January 2016. Final Report EBA/RTS/2016/01 13 January 2016 Final Report Final draft regulatory technical standards amending Commission Delegated Regulation (EU) No 1222/2014 on the specification of the methodology for the identification

More information

The EBA s competence to deliver an opinion is based on the sixth subparagraph of Article 10(1) of Regulation (EU) No 1093/2010 2.

The EBA s competence to deliver an opinion is based on the sixth subparagraph of Article 10(1) of Regulation (EU) No 1093/2010 2. OPINION ON RTS ADDITIONAL COLLATERAL OUTFLOWS EBA/Op/2016/08 03/05/2016 Opinion of the European Banking Authority on the Commission s intention not to endorse the draft Regulatory Technical Standards on

More information

Dutch Mortgage Market Pricing On the NMa report. Marco Haan University of Groningen November 18, 2011

Dutch Mortgage Market Pricing On the NMa report. Marco Haan University of Groningen November 18, 2011 Dutch Mortgage Market Pricing On the NMa report Marco Haan University of Groningen November 18, 2011 Introductory remarks My comments are complementary: I do not focus so much on this market as such, more

More information

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a RECOMMENDATION OF THE COUNCIL AND OF THE EUROPEAN PARLIAMENT

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a RECOMMENDATION OF THE COUNCIL AND OF THE EUROPEAN PARLIAMENT COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 12.10.2004 COM(2004) 642 final 2004/0239 (COD) Proposal for a RECOMMENDATION OF THE COUNCIL AND OF THE EUROPEAN PARLIAMENT on further European cooperation

More information

COUNCIL OF THE EUROPEAN UNION. Brussels, 29 September 2009 13707/09 LIMITE PI 93

COUNCIL OF THE EUROPEAN UNION. Brussels, 29 September 2009 13707/09 LIMITE PI 93 COUNCIL OF THE EUROPEAN UNION Brussels, 29 September 2009 13707/09 LIMITE PI 93 WORKING DOCUMENT from: General Secretariat of the Council to: Working Party on Intellectual Property (Patents) No. prev.

More information

BUBBLE JUICE CC AMERICAN DJ

BUBBLE JUICE CC AMERICAN DJ Page : 1/6 HEALT & SAFETY PRODUCT DATA SHEET ( Regulation CE n 1907/2006 changed) BUBBLE JUICE CC Code: 381020 AMERICAN DJ A.D.J. Supply Europe B.V. Junostraat 2 6468 EW Kerkrade - NETHERLANDS Page : 2/6

More information

Working together for healthier living

Working together for healthier living Working together for healthier living What is compounding? Compounding is the art and science of preparing custom medications to meet patients unique needs and prescribers exact specifications. The practice

More information

Drafted by ENTSOE. NCs impact DSOs grid ooperation. Approved at EU level. Network Codes. Significant Costs for EU DSOs - billions

Drafted by ENTSOE. NCs impact DSOs grid ooperation. Approved at EU level. Network Codes. Significant Costs for EU DSOs - billions Network Codes NCs impact DSOs grid ooperation Significant Costs for EU DSOs - billions Approved at EU level Comitology - Binding legislation for MS Drafted by ENTSOE Network Codes Actors involved DSOs

More information

Georgios Katsarakis Europäische Kommission

Georgios Katsarakis Europäische Kommission Georgios Katsarakis Europäische Kommission Implementing the Construction Products Regulation (EU) 305/2011 G. Katsarakis European Commission, DG Enterprise and Industry Unit B-1: Sustainable Industrial

More information

SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING. Enzymatic Drain Cleaner and Maintainer

SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING. Enzymatic Drain Cleaner and Maintainer SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier Product name Product No. Enzymatic Drain Cleaner and Maintainer C187 1.2. Relevant identified uses

More information

TERMS OF REFERENCE Electronic Communications Resilience and Response Group (EC RRG)

TERMS OF REFERENCE Electronic Communications Resilience and Response Group (EC RRG) TERMS OF REFERENCE Electronic Communications Resilience and Response Group (EC RRG) Goal Aims To ensure the availability of Electronic Communications infrastructure for the UK and provide an industry emergency

More information

COMMISSION OF THE EUROPEAN COMMUNITIES

COMMISSION OF THE EUROPEAN COMMUNITIES EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 28.11.2008 COM(2008) 798 final COMMUNICATION FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE

More information

EMA Update Clinical Trials

EMA Update Clinical Trials EMA Update Clinical Trials Fergus Sweeney, Head, Compliance and Inspections, European Medicines Agency 16 October 2012 An agency of the European Union Disclaimer The views presented in this presentation/these

More information

Lean Maintenance & Asset Management The Best of Both Worlds

Lean Maintenance & Asset Management The Best of Both Worlds Lean Maintenance & Asset Management The Best of Both Worlds Ir. Martin van den Hout CMRP : Asset Management, Maintenance & Reliability Introductie 2 Ir. Martin van den Hout Certified Maintenance & Reliability

More information

COMMISSION RECOMMENDATION. of XXX. on the right to legal aid for suspects or accused persons in criminal proceedings

COMMISSION RECOMMENDATION. of XXX. on the right to legal aid for suspects or accused persons in criminal proceedings EUROPEAN COMMISSION Brussels, XXX C(2013) 8179/2 COMMISSION RECOMMENDATION of XXX on the right to legal aid for suspects or accused persons in criminal proceedings EN EN COMMISSION RECOMMENDATION of XXX

More information

16094/14 MM/mj 1 DG E - 1C

16094/14 MM/mj 1 DG E - 1C Council of the European Union Brussels, 26 November 2014 (OR. en) 16094/14 OUTCOME OF PROCEEDINGS From: On: 25 November 2014 To: CULT 134 AUDIO 69 MI 945 RELEX 980 STATIS 128 Education, Youth, Culture

More information

Reporting Changes to your Notified Body

Reporting Changes to your Notified Body Reporting Changes to your Notified Body Vicky Medley - Head of QMS, Medical Devices September 2015 1) Requirements & Guidance 2) Reporting Changes - What, When, Why & How 3) Some examples 4) Summary &

More information

IP-NBM. Copyright Capgemini 2012. All Rights Reserved

IP-NBM. Copyright Capgemini 2012. All Rights Reserved IP-NBM 1 De bescheidenheid van een schaker 2 Maar wat betekent dat nu 3 De drie elementen richting onsterfelijkheid Genomics Artifical Intelligence (nano)robotics 4 De impact van automatisering en robotisering

More information

Samenwerken in/aan een green deal Opties voor CO2 reductie op en rondom het spoor

Samenwerken in/aan een green deal Opties voor CO2 reductie op en rondom het spoor Samenwerken in/aan een green deal Opties voor CO2 reductie op en rondom het spoor Maart 2013 TRANSPORT minder diesel verbruik = minder CO2 uitstoot Doelstelling voor hybride locomotief Lage snelheid Hoge

More information

Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry

Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry EUROPEAN COMMISSION Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs Resources Based, Manufacturing and Consumer Goods Industries Chemicals Industry Version March 2015 QUESTIONS

More information

Tooth Whitening/Dental Bleaching Products Containing Hydrogen Peroxide in the European Union

Tooth Whitening/Dental Bleaching Products Containing Hydrogen Peroxide in the European Union Tooth Whitening/Dental Bleaching Products Containing Hydrogen Peroxide in the European Union Proposals to Modify Current Regulations - Submitted to the European Union Scientific Committee on Consumer Products

More information

Importing pharmaceutical products to China

Importing pharmaceutical products to China Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval

More information

000917/EU XXV. GP. Eingelangt am 06/11/13. Brussels, 6 November 2013 (OR. en) COUNCIL OF THE EUROPEAN UNION 15394/13 ENV 982 MI 927 DELACT 66

000917/EU XXV. GP. Eingelangt am 06/11/13. Brussels, 6 November 2013 (OR. en) COUNCIL OF THE EUROPEAN UNION 15394/13 ENV 982 MI 927 DELACT 66 000917/EU XXV. GP Eingelangt am 06/11/13 COUNCIL OF THE EUROPEAN UNION Brussels, 6 November 2013 (OR. en) 15394/13 ENV 982 MI 927 DELACT 66 COVER NOTE From: Secretary-General of the European Commission,

More information

European Regulatory Newsletter July - September 2013

European Regulatory Newsletter July - September 2013 European Regulatory Newsletter July - September 2013 Introduction CROMSOURCE is committed to sharing our expertise with our clients and future clients. This reflects the first part of our Advise Agree

More information

European Council Brussels, 2 February 2016 (OR. en)

European Council Brussels, 2 February 2016 (OR. en) European Council Brussels, 2 February 2016 (OR. en) EUCO 4/16 NOTE To: Subject: Delegations Draft Decision of the Heads of State or Government, meeting within the European Council, concerning a New Settlement

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Ref. Ares(2011)1044649-03/10/2011 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Pharmaceuticals SANCO/D3/RSR/iv(2011)ddg1.d3. 1137738 Update 1 October 2011 HANDLING

More information

UK Indirect Tax Conference 2015 How does the EU do VAT? Aili Nurk 11 November 2015

UK Indirect Tax Conference 2015 How does the EU do VAT? Aili Nurk 11 November 2015 UK Indirect Tax Conference 2015 How does the EU do VAT? Aili Nurk 11 November 2015 Contents EU Policy lifecycle of a tax change Influencing making it work in practice EU VAT agenda open dossiers Q&A 2

More information